These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 12724286)

  • 1. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48.
    Brown MH; Boles K; van der Merwe PA; Kumar V; Mathew PA; Barclay AN
    J Exp Med; 1998 Dec; 188(11):2083-90. PubMed ID: 9841922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies.
    Kwantwi LB
    Clin Transl Oncol; 2024 Aug; ():. PubMed ID: 39212911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors.
    Gunes M; Rosen ST; Shachar I; Gunes EG
    Front Immunol; 2024; 15():1297473. PubMed ID: 38476238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells and their activation status in normal pregnancy.
    Mosimann B; Wagner M; Shehata H; Poon LC; Ford B; Nicolaides KH; Bansal AS
    Int J Reprod Med; 2013; 2013():906813. PubMed ID: 25763390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2B4 functions as a co-receptor in human NK cell activation.
    Sivori S; Parolini S; Falco M; Marcenaro E; Biassoni R; Bottino C; Moretta L; Moretta A
    Eur J Immunol; 2000 Mar; 30(3):787-93. PubMed ID: 10741393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human choriocarcinoma cell resistance to natural killer lysis due to defective triggering of natural killer cells.
    Avril T; Iochmann S; Brand D; Bardos P; Watier H; Thibault G
    Biol Reprod; 2003 Aug; 69(2):627-33. PubMed ID: 12724286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.
    Colonna M; Nakajima H; Cella M
    J Leukoc Biol; 1999 Nov; 66(5):718-22. PubMed ID: 10577499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny, specific functions and receptors of human natural killer cells.
    Moretta L; Ciccone E; Poggi A; Mingari MC; Moretta A
    Immunol Lett; 1994 May; 40(2):83-8. PubMed ID: 8088876
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.